CLINICAL_TRIALS
withdrawal
· 2026-03-03
Clinical Trial Update: Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population [NA]
Summary
A clinical trial comparing cytology and molecular screening for detecting cervical reactive cellular changes in the general population has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Timser SAPI de CV | Conditions: Atypical Squamous Cell of Undetermined Significance, ASC-US | NA | Status: WITHDRAWN